Is the current pharmaceutical R&D model sustainable, and if not, can 'smart regulation' ensure that regulatory regimes are suitable for the emergent science, technologies and therapies that have the potential to transform healthcare and the industries that provide for it?
Mittra, James; Tait, Joyce and Wield, David (2011). The future of pharmaceutical innovation: new challenges and opportunities. IPTonline(36) pp. 32–34.
Mittra, James; Tait, Joyce and Wield, David (2011). The future of pharmaceutical innovation: new challenges and opportunities. IPTonline(36) pp. 32–34.